Search
for
Sort by
Research 391–420 of 1000+
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years.
- BH03: Systemic sclerosis and frontal fibrosing alopecia: a novel combination of scarring alopecia
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Learning from nudity: lessons from the nude phenotype
- Immune cell regulation of the hair cycle
- The Changing Landscape of Alopecia Areata: The Translational Landscape
- Novel therapies for alopecia areata: The era of rational drug development
- Pharmacological Treatment of Alopecia
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Research Progress on the Application of Stem Cells in Hair Regeneration
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- British Hair and Nail Society
- Upadacitinib is effective in treating psoriasis combined with lichen planus: a case report
- Kaempferol enhances hair growth by regulating JAK3/STAT6 and TGF-β/Smad signaling in human dermal papilla cells and a C57BL/6 mousemodel
- When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Letter to the Editor: A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Healthcare System
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates